Discover open access scientific publications

Search, annotate, share and cite publications

Publications by V. Zellmer

Modulation of Gene Expression and Cell-Cycle Signaling Pathways by the EGFR Inhibitor Gefitinib (Iressa) in Rat Urinary Bladder Cancer

Cancer Prevention Research

English

Related publications

Glioblastoma Multiforme Stem Cell Cycle Arrest by Alkylaminophenol Through the Modulation of EGFR and CSC Signaling Pathways

Cells

2020

English

Targeted Inhibition of Heat Shock Protein 90 Disrupts Multiple Oncogenic Signaling Pathways, Thus Inducing Cell Cycle Arrest and Programmed Cell Death in Human Urinary Bladder Cancer Cell Lines

Cancer Cell International

English

The Prognostic Value of Cell Cycle Gene Expression Signatures in Muscle Invasive, High-Grade Bladder Cancer

English

Figure 3: Inhibition of EGFR by Gefitinib and RNA Interference Impairs mESCs Cell Cycle and Self-Renewal Related Genes Expression.

English

Metformin and Gefitinib Cooperate to Inhibit Bladder Cancer Growth via Both AMPK and EGFR Pathways Joining at Akt and Erk

Scientific Reports

Multidisciplinary

2016

English

Gefitinib Reverses TRAIL Resistance in Human Bladder Cancer Cell Lines via Inhibition of AKT-Mediated X-Linked Inhibitor of Apoptosis Protein Expression

Cancer Research

Oncology

2007

English

Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer

Clinical Cancer Research

Cancer Research

Oncology

2004

English

Novel HSP90-PI3K Dual Inhibitor Suppresses Melanoma Cell Proliferation by Interfering With HSP90-EGFR Interaction and Downstream Signaling Pathways

International Journal of Molecular Sciences

Organic Chemistry

Molecular Biology

Theoretical Chemistry

Inorganic Chemistry

Computer Science Applications

English

Gefitinib Induces Premature Senescence in Non-Small Cell Lung Cancer Cells With or Without EGFR Gene Mutation

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by V. Zellmer

Modulation of Gene Expression and Cell-Cycle Signaling Pathways by the EGFR Inhibitor Gefitinib (Iressa) in Rat Urinary Bladder Cancer

Related publications

Glioblastoma Multiforme Stem Cell Cycle Arrest by Alkylaminophenol Through the Modulation of EGFR and CSC Signaling Pathways

Targeted Inhibition of Heat Shock Protein 90 Disrupts Multiple Oncogenic Signaling Pathways, Thus Inducing Cell Cycle Arrest and Programmed Cell Death in Human Urinary Bladder Cancer Cell Lines

The Prognostic Value of Cell Cycle Gene Expression Signatures in Muscle Invasive, High-Grade Bladder Cancer

Figure 3: Inhibition of EGFR by Gefitinib and RNA Interference Impairs mESCs Cell Cycle and Self-Renewal Related Genes Expression.

Metformin and Gefitinib Cooperate to Inhibit Bladder Cancer Growth via Both AMPK and EGFR Pathways Joining at Akt and Erk

Gefitinib Reverses TRAIL Resistance in Human Bladder Cancer Cell Lines via Inhibition of AKT-Mediated X-Linked Inhibitor of Apoptosis Protein Expression

Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer

Novel HSP90-PI3K Dual Inhibitor Suppresses Melanoma Cell Proliferation by Interfering With HSP90-EGFR Interaction and Downstream Signaling Pathways

Gefitinib Induces Premature Senescence in Non-Small Cell Lung Cancer Cells With or Without EGFR Gene Mutation